The announcement on the 19/07/2023 said
Pharmacokinetic Results – Potential for R327 to be Used to Treat Sepsis
The results showed a significant dose-dependent concentration of R327 in both the urine and the
plasma, highlighting the potential of R327 as a potential treatment of sepsis and
complicated/uncomplicated UTIs.
Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-93
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.005(1.67%) |
Mkt cap ! $87.95M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.3¢ | $22.01K | 70.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25691 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 4296 | 3 |
View Market Depth
| Last trade - 15.21pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |